Work

Treatment With Anakinra, a Recombinant IL-1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD Colitis

Year: 2015

Type: article

Source: The American Journal of Gastroenterology

DOI: 10.1038/ajg.2015.135

Authors: Katherine J Hahn, Nancy Ho, Lynne Yockey, Samantha Kreuzberg, Janine Daub, Amy Rump, Beatriz E Marciano, Martha Quezado, Harry L Malech, Steven M Holland, Theo Heller, Christa S Zerbe

Institutions: Georgetown University Medical Center, MedStar Georgetown University Hospital, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Allergy and Infectious Diseases, National Cancer Institute

Language: English

Topic: Immunodeficiency and Autoimmune Disorders

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W762550394

FWCI: 2.349

Cites: 7

Cited by: 60

Related to: 10